前列腺癌(PCa)的雄激素剥夺疗法(ADT)与副作用有关,这些副作用可能导致负面的身体形象和幸存者的男性自尊心低下。我们将一组ADT后的PCa幸存者与ADT初治患者进行了比较,期望ADT组表现出较低的男性自尊。我们还期望具有霸权男性气质理想的患者表现出较差的男性自尊,并且我们假设ADT会缓和这种关系,期望PCa患者在ADT上具有更强的霸权理想,以显示研究参与者中最差的男性自尊得分。
我们比较了57名ADT患者(Mage=64.16(7.11))和59名ADT初治患者(Mage=65.25(5.50)),在男性自尊量表(MSES)上,身体图像比例(BIS),和霸权男性理想量表(HMIS)。
虽然两组在男性自尊(F[1,115]=3.46,p=0.065,ηp2=0.029)和身体形象(F[1,115]=3.46,p=0.065,ηp2=0.029)方面没有显着差异,年龄较小与较高的身体形象问题显着相关(F[1,115]=8.63,p<0.01,ηp2=0.071,β=-0.30)。霸权男性气质显著预测更多男性自尊相关问题(t(2,114)=2.31,β=0.375,p<0.05)。ADT并没有缓和这种关系。
结果表明,无论ADT状态如何,支持霸权男性气质可能是男性自尊低下的危险因素,并且年龄较小与PCa幸存者的负面身体形象有关。
这些结果表明,在为PCa幸存者提供支持时,纳入与霸权男子气概有关的主题的重要性,在讨论治疗副作用时,以及在生存的后期阶段。该试点还表明,无论治疗计划如何,年轻的PCa幸存者都可能受益于以身体形象为中心的支持。
Androgen deprivation therapy (ADT) for Prostate Cancer (PCa) is associated with side effects that could lead to negative body image and low masculine self-esteem of survivors. We compared a group of PCa survivors following ADT with ADT-naïve patients, expecting the ADT group to show lower masculine self-esteem. We also expected patients with hegemonic masculinity ideals to show poorer masculine self-esteem and we hypothesized that ADT would moderate this relationship, expecting PCa patients on ADT with stronger hegemonic ideals to show the worst masculine self-esteem scores among study participants.
We compared 57 PCa survivors on ADT (Mage = 64.16 (7.11)) to 59 ADT-naïve patients (Mage = 65.25 (5.50)), on the Masculine Self-Esteem Scale (MSES), Body Image Scale (BIS), and Hegemonic Masculinity Ideals Scale (HMIS).
While the two groups did not significantly differ on masculine self-esteem (F [1, 115] = 3.46, p = 0.065, ηp 2 = 0.029) and body image (F [1, 115] = 3.46, p = 0.065, ηp 2 = 0.029), younger age was significantly associated with higher body image issues (F [1, 115] = 8.63, p < 0.01, ηp 2 = 0.071, β = -0.30). Hegemonic masculinity significantly predicted more masculine self-esteem related issues (t (2, 114) = 2.31, β = 0.375, p < 0.05). ADT did not moderate this relationship.
The results suggest that endorsing hegemonic masculinity could represent a risk factor for low masculine self-esteem regardless of ADT status and that younger age is associated with negative body image among PCa survivors.
These results suggest the importance of inclusion of topics related to hegemonic masculinity when providing support to PCa survivors, both when discussing treatment side effects, as well as in the later phases of survivorship. This pilot also suggests that younger PCa survivors might benefit from body-image focused support regardless of treatment plan.